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Abstract: Over the past years, clinical guidelines have increasingly become part of the clinical daily practice in order to 
provide best available Evidence-Based-Medicine services. Hence, their formalization as computer 
interpretable guidelines (CIG) and their implementation in clinical decision support systems (CDSSs) are 
emerging to support clinicians in their decision making process and potentially improve medical outcomes. 
However, guideline compliancy in the clinical daily practice is still “low”. Some of the reasons for such low 
compliance rate are (i) lack of a complete guideline to cover special clinical cases (e.g. oncogeriatric cases), 
(ii) absence of parameters that current guidelines do not consider (e.g. lifestyle) and (iii) absence of up-to-
date guidelines due to lengthy validation procedures. In this paper we present a novel method to build a CDSS 
that, besides integrating CIGs, stores experts’ knowledge to enrich the CDSS and provide best support to 
clinicians. The knowledge includes new evidence collected over time by the systematic usage of CDSSs.  
1 INTRODUCTION 
In order to offer the best available care, medical 
practice adopts the Evidence-Based-Medicine (EBM) 
principle, defined as “the conscientious, explicit and 
judicious use of current best evidence in making 
decisions about care of individual patients” (Sackett 
et al., 1996). In the 90s clinical practice guidelines 
(CPGs) start to appear as rigorous evaluations of 
different clinical activities that improved the clinical 
practice and developed health care processes 
(Grimshaw and Russell, 1994), so that clinicians 
could follow EBM. However, clinicians still found 
barriers to adhere to CPGs (Cabana MD et al., 1999). 
Some of these barriers were lack of awareness, lack 
of familiarity, lack of agreement, lack of outcome 
expectancy or the inertia to previous practice. These 
barriers are still valid in the current practice. 
In order to overcome some of the main obstacles, 
during the last decade multiple CPGs have been 
formalized in an electronic way, i.e. computer 
interpretable guidelines (CIG), and applied in Clinical 
Decision Support Systems (CDSSs) (B. Séroussi et 
al., 2013). Nevertheless, it was discovered that CPGs 
still have limitations. For instance, in the context of 
breast cancer (BC) some factors such as elderly 
patients, multifocal tumours, occurrence of 
micrometastasis on lymph-node and patient choice 
are causes of CPGs non-compliance (Chéreau et al., 
2011; Landercasper et al., 2006; Lebeau et al., 2011; 
B. Séroussi et al., 2013). 
In this paper we present a method to acquire 
expert knowledge in order to develop a knowledge-
augmented guideline-based CDSS. It results in the 
development of new tools to support clinicians on 
their decision making process for cases that have low 
evidence (e.g. oncogeriatric cases) or where other 
aspects (e.g. patient preferences) are crucial.  
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 The rest of this paper is organized as follows. 
Section 2 presents the state of the art on CIG 
compliance. Section 3 presents the method to 
augment the guideline-based CDSS with expert´s 
knowledge. Section 4 presents the application of such 
method in an EU project, DESIREE, developed in the 
context of breast cancer. Section 5 proposed a short 
discussion on the presented method and Section 6 
concludes the paper and gives some future work lines. 
2 STATE OF THE ART 
2.1 Guideline Compliance 
Variations in medical practices have been observed 
for decades, questioning the quality of care (Mercuri 
and Gafni, 2011). CPGs compliance is one of the 
primary performance measures to assess the quality 
of medical practice. McGlynn et al. (McGlynn et al., 
2003) reported that 54.9% of the studied patient 
population received CPGs’ based recommended care, 
which vary from 10% to 78%. In their work they 
reported that for BC 75.7% were consistent with 
recommended care, based on 9 quality indicators. 
Other studies also demonstrated suboptimal guideline 
compliance levels in BC (Adegboyega et al., 2015; 
Landercasper et al., 2006; Lebeau et al., 2011; 
Wöckel et al., 2010). The published levels of 
guideline compliance range from 12% (Lebeau et al., 
2011) to 100% (Adegboyega et al., 2015), depending 
on the definition of guideline compliance and the 
level of abstraction of the guideline. For instance, 
Wöckel et al. (Wöckel et al., 2010) reported 80% of 
adherence to German-S3-BC guideline for surgery 
and for hormone therapy, and 71% for chemotherapy, 
indicating different compliance levels for the 
different components of the care plan. Similarly, 
Lebeau et al. (Lebeau et al., 2011) reported high level 
of guideline compliance, but also said that 
“management of non-metastatic BC was fully 
compliant (considering jointly 20 quality criteria)”. 
2.2 Causes Associated with Guideline 
Non-Compliance  
The causes of variations in care delivery are 
multifactorial. A review by Flottorp et al. (Flottorp et 
al., 2013) identified a list of 51 determinants of 
practice grouped in seven domains: guideline factors, 
individual health professional factors, patient factors, 
professional interactions, incentives and resources, 
capacity for organisational change, and social, 
political, and legal factors.  
However, effective guideline-based CDSSs 
(Beeler et al., 2014; Roshanov et al., 2013) provide a 
framework for logging non-compliance cases and 
learn from them. As demonstrated by Séroussi et al. 
(B. Séroussi et al., 2013), guideline compliance 
increases by using guideline-based CDSS. 
Additionally, Bouaud et al. (Bouaud and Séroussi, 
2011) determined the main factors related with CPG 
non-compliance and reported the distribution of non-
compliance causes. Here, we list these causes 
reported in (Bouaud and Séroussi, 2011):    
 Patient preferences: When patients receive 
more complete information about the benefits 
and risks of different treatment options, the 
patients made their own active, informed 
decisions (Leonard et al., 2011). This decision 
is influenced by their personal preferences.  
 Evolution of medical knowledge: CPG 
knowledge may not consider latest scientific 
publications and clinical essays, and hence, 
they may lag behind ‘last’ evidence (B. 
Séroussi et al., 2013). This may include that 
‘new’ parameters are not being considered in 
the applied guidelines.  
 Specific situations: Rare situations that require 
specific clinical research are also a cause of 
non-compliance. For example, in BC scenarios 
shown in (Parks et al., 2012; Schnitt, 1998; B 
Séroussi et al., 2013), microinvasion, 
neadjuvant situations and oncogeriatry 
conditions are the main causes that lead into 
non-compliance situations. 
 Medical choices: One of the main cause of 
non-compliance is a medical decision that is 
prioritized over the guideline recommendation. 
For example, in (Bouaud and Séroussi, 2011), 
the study reported that BC multidisciplinary 
staff meetings’ choice (i.e. breast units choice) 
is the main reason reported as the cause for 
CPG non-compliance.  
 Others: Finally, it may be other reasons that 
lead into CPG non-compliancy that do not 
belong to any of the previously reported causes. 
Some studies provide tools to support clinicians 
in understanding the reasons of non-compliancy 
(Hussain et al., 2007). Others exploit the stored 
patient information to predict patient worsening and 
prevent potential emergencies  (Colantonio et al., 
2008).  Yet, there is no evidence that all the 
information related to the whole decision making 
process (such as additional patient data, the decision 
criteria for giving a specific treatment and patient 
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 outcomes) is stored and exploited over time to enrich 
the CDSS and provide better decision support to 
decision makers in prospective cases.  
3 METHOD TO AUGMENT 
GUIDELINE-BASED CDSS 
Here we present a method that enables the 
exploitation of the implicit knowledge used in a 
decision making process. The method is presented in 
the following subsections: Section 3.1 presents the 
starting point, which applies the clinical guideline 
model, Section 3.2 presents the second stage, which 
describes the acquisition process of experts’ 
knowledge and Section 3.3 presents how such 
experts’ knowledge is exploited.  
3.1 Clinical Guideline Model 
As discussed in Section 1, CPGs are intended to 
optimize patient care. Therefore, in this initial stage a 
clinical guideline model is developed. The clinical 
guideline model incorporates (i) different guidelines 
based on users’ needs, (ii) updated clinical guidelines 
or studies, so that the provided recommendations 
correspond to the latest available evidence, and 
detects (iii) potential inconsistencies that could be 
reflected on the implemented guidelines.  
3.2 Experts’ Knowledge Acquisition 
The second stage of this method focuses on experts’ 
knowledge acquisition and storage.  
We developed a flexible solution that enables the 
storage of each decisional event (Figure 1). Each 
decisional event reflects all the rationality for taking 
a decision and the consequences of such decision. 
Hence, we define the decisional event as  ࡰ࢔ ൌ	൏ࡼ࢏, ࡾ࢐		ࡲࡰ, ࡯࢑, ࡱ,ࡻሺ࢚ሻ ൐	, where (i) Pi is a set of 
patient parameters involved in the decision-making 
process, (ii) Rj is a set of clinical conditions (e.g. 
rules) wherein such parameters have been analysed, 
which results in a set of recommendations (iii) FD is 
a final decision that is taken by the decision maker, 
(iv) Ck is a set of criteria for which the final decision 
is made (which could be a patient parameter), (v) E is 
the executed treatment (usually, same as the final 
decision) and (vi) O(t) is the health outcomes of a 
patient measured over time t (e.g. (“ICHOM – 
International Consortium for Health Outcomes 
Measurement,” n.d.)).  
 
 
Figure 1: Decisional event and decisional history. 
As shown in Figure 1, the storage of decisional 
events over time lead into a decisional history. The 
decisional history is later used to retrieve conclusions 
or discover new knowledge (Section 3.3). 
3.3 Experts Knowledge Exploitation     
Here we present the three usages of this decisional 
history: (i) recommendations assessment, (ii) patient 
similarity based recommendations and (iii) 
knowledge discovery to extend the knowledge base.  
3.3.1 Recommendation Assessment   
As presented by (Fox et al., 2009), “the current 
guideline development lifecycle does not provide 
appropriate tools to assess their impact on clinical 
practice”. The proposed system is able to evaluate the 
decisions taken quantitatively (e.g. based on the 
number of times the recommendation was followed) 
and qualitatively (e.g. based on the patient outcomes 
– when the results are successful or match the defined 
decision criteria). This quantitative and qualitative 
measurements are presented to clinicians during the 
clinical decision making process to provide enriched 
information of the given recommendations. 
3.3.2 Patients’ Similarities  
The system also applies similarity features between 
different patients and their results to support 
clinicians in their decision making process. For that, 
the system uses different metrics to determine which 
(clinical) parameters have higher impact when 
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 determining how similar a patient could be to a 
retrospective patient (e.g. age range, TNM 
classification etc.). In cases where the benefits and 
harms of a specific treatment are not clear, clinicians 
are able to consult previous similar patient cases and 
their outcome before taking a decision. The previous 
patient cases could be specific patient cases, or 
‘model’ cases that summarise n past cases. 
3.3.3 Knowledge Discovery 
The experience acquired from the decisional history 
may enable different type of knowledge acquisition. 
Here we present the two types of knowledge 
considered in our research.  
Firstly, the information from a large number of 
cases enables the adjustment of CPGs and protocols´ 
clinical conditions, e.g. in a form of a rule. For that, 
the scope of the criteria is redefined based on the 
cases where the given guideline-based 
recommendation is being followed with successful 
results. This is implemented using machine learning 
techniques. For example, if a decision criterion is 
parameter ܽ ∈ ሾ0.5, 1.5ሿ, after applying machine 
learning techniques the system recognizes that the 
recommendation is being successful only when ܽ ∈
ሾ0.8, 1.3ሿ. It also detects when a parameter, not 
previously included into the clinical condition for the 
decision making process, is determinant and should 
be part of the existing decision rule.  
Secondly, large number of non-compliant cases 
with good or better results than the ones that follows 
the CPGs may lead into an extension of the CPGs´ 
clinical conditions (e.g. rules) by generating ‘new’ 
branches. This ‘new’ branches may include 
recommendations (treatment actions) that are not 
considered in the available CPGs (e.g. “clinical trial”) 
or may include recommendations that are in the 
CPGs, but that are not considered for the given case. 
This cases could make the knowledge base either 
more restrictive when a rule becomes more precise, 
but also could extend it with further procedures that 
were not included in the knowledge base.  
In both adjustment and extension cases, in order 
to include the ‘new’ knowledge into the CDSS, the 
system verifies if the outcomes are positives and 
informs clinicians about its potential usage. If 
approved, this knowledge is included into the 
knowledge base for the CDSS (Figure 2). 
Nevertheless, the system provides the information of 
the recommendation source. This way clinicians are 
aware if the recommendation is guideline based or 
created automatically by the system based on the 
recorded experience or patient similarity properties. 
4 DESIGN IN DESIREE 
This study is being performed in the context of a 
European H2020 project, named DESIREE. In this 
section we present DESIREE project (Section 4.1) 
and the data flow diagram that represents our 
methodology within DESIREE (Section 4.2). 
 
Figure 2: Data flow diagram. 
4.1 DESIREE 
DESIREE aims to provide decision support on the 
available therapy options by incorporating evidence 
based guidelines and experience from previous cases 
and outcomes. Hence, DESIREE goes beyond the 
limitations of existing guideline-based decision 
support systems. Such a system targets breast cancer 
(BC) cases, which is one of the most common and 
most deadly type of cancer affecting woman in the 
EU countries, with more than 460,000 new cases and 
130,000 deaths in 2012 (Ferlay et al., 2013).  
The users of such system are medical domain 
experts involved on breast units (BU) where patients’ 
diagnosis and treatment decisions are taken. Hence, 
the system goal is to support BU during their weekly 
meetings in their multidisciplinary decision making 
process by providing not only CPGs based decision 
support, but also additional information extracted 
from previous cases over time.  
4.2 DESIREE   
The data flow diagram presented in Figure 2 is a high 
level representation of DESIREE platform. Since 
DESIREE is developed in the context of BC, in the 
depicted figure, Breast Units (BU) are the clinical 
experts that make the final decision. Here, we 
describe each block presented in Figure 2, omitting 
the blocks that correspond to the data presented in 
Section 3.2. 
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  Narrative Guidelines: In our methodological 
approach, the starting point is the analysis of 
representative and narrative CPGs used in BC 
care.  
 Computer Interpretable Guidelines: 
Knowledge engineers extract the relevant 
information from CPGs and formalize it in a 
CIG. This covers the recommendations given 
by guidelines for primary BC in several stages 
of the whole treatment till the patient is 
discharged. Hence, the CIG consider the 
previous treatments and the outcomes of them 
for the coming decision making action.  
 Knowledge: The knowledge database stores 
knowledge from the CIG or from the decisional 
history exploitation´s “new” knowledge. 
 Rule-based Engine: The rule-based engine is 
able to generate recommendations having as 
input the structured knowledge. Then, if patient 
data fulfils the clinical condition, the rules are 
fired and the engine generates one or more 
recommendations. 
 Knowledge Discovery:  Based on a large set of 
information stored in the decisional history, the 
system is capable of retrieving knowledge as 
discussed in Section 3.3.   
5 DISCUSSION 
The presented method overcomes some limitations of 
current guideline-based CDSS by providing enriched 
recommendations and additional information to 
clinicians in order to support them best in their 
decision making process. For that, we develop a new 
information structure based on decisional events. A 
decisional event stores the whole set of information 
used in the decision making process, including the 
consequences of the final decision, such as patient´s 
outcomes (e.g. quality of life).  
Here we present some of the potential benefits and 
limitations of the proposed method. Firstly, the 
system promotes the usage of CPGs. Additionally, it 
assess the impact of the guidelines on clinical practice 
(Section 3.3.1), which is one of the critical factors  
detected by (Fox et al., 2009). Secondly, the system 
flexibility enables the storage of additional valuable 
information, such as the decision criteria, that could 
be used to adjust or/and extend the clinical conditions 
of the given protocols and CPGs over time (Section 
3.3.3). This way it helps overcoming some of the 
limitations of current CPGs presented in Section 2, 
such as the impact of specific situations. This 
diverges from the work done in other projects, such 
as MobiGuide (Larburu et al., 2015), where the 
guidelines are customized and made context-aware 
beforehand during the knowledge engineering phase, 
and not over time depending on previous cases. 
Neither we focus on the discovery of temporal rules 
from time-stamped data, like in (Sacchi et al., 2007). 
Our study aims to discover rules from previous cases 
tracking each case to assess the outcomes and 
considering further information often not taken into 
account in current CPGs, such as the implicit 
knowledge of clinicians. Finally, the presented 
method combines both the CPGs and the knowledge 
generated automatically by the system based on their 
experience, which overcomes the requirements 
expressed by clinicians in (Miranda-Mena et al., 
2006): “clinicians want a system that combines the 
protocol (or CPG) and their proper knowledge to 
suggest treatments”.  
6 CONCLUSIONS & FUTURE 
WORK 
The hypothesis of this research is that such approach 
is more useful for clinicians, which expect a dynamic 
system that not only considers available CPGs and 
protocols, but also a system that is able to learn from 
the stored information over time to provide enriched 
decision support system.  
In future work we aim to present among others the 
following points: (i) the tools used to convert the 
information acquired by experience into knowledge 
to extend and adjust the CPGs and protocols; (ii) a 
digital patient model ontology used for the CDSS, and 
particularly for similarity purposes; (iii) the 
methodology to assess the recommendations 
applying different metrics (survival rate, overall well-
being, physical functioning etc.); and (iv) the 
validation of the system in a representative number of 
patients and the results.  
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